These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

19 related articles for article (PubMed ID: 5088491)

  • 1. Control and utilization of ruthenium and rhodium metal complex excited states for photoactivated cancer therapy.
    Knoll JD; Turro C
    Coord Chem Rev; 2015 Jan; 282-283():110-126. PubMed ID: 25729089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ru(bpy)2(5-cyanouracil)2]2+ as a potential light-activated dual-action therapeutic agent.
    Garner RN; Gallucci JC; Dunbar KR; Turro C
    Inorg Chem; 2011 Oct; 50(19):9213-5. PubMed ID: 21879748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Ethynyluracil (776C85): a potent modulator of the pharmacokinetics and antitumor efficacy of 5-fluorouracil.
    Baccanari DP; Davis ST; Knick VC; Spector T
    Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11064-8. PubMed ID: 8248211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of catabolism in pyrimidine utilization for nucleic acid synthesis in vivo.
    Cooper GM; Dunning WF; Greer S
    Cancer Res; 1972 Feb; 32(2):390-7. PubMed ID: 5058194
    [No Abstract]   [Full Text] [Related]  

  • 5. Modulation of 5-fluorouracil catabolism in isolated rat hepatocytes with enhancement of 5-fluorouracil glucuronide formation.
    Sommadossi JP; Gewirtz DA; Cross DS; Goldman ID; Cano JP; Diasio RB
    Cancer Res; 1985 Jan; 45(1):116-21. PubMed ID: 3965128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A note on in vitro inhibition of thymine degradation by some pyrimidine analogues and related products.
    Agarwal DP; Eickhoff K; Goedde HW
    Z Naturforsch B; 1969 Apr; 24(4):469-70. PubMed ID: 4389608
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibitory effects of pyrimidine, barbituric acid and pyridine derivatives on 5-fluorouracil degradation in rat liver extracts.
    Tatsumi K; Fukushima M; Shirasaka T; Fujii S
    Jpn J Cancer Res; 1987 Jul; 78(7):748-55. PubMed ID: 3114201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of rat dihydropyrimidine dehydrogenase by 5-cyanouracil in vitro.
    Dorsett MT; Morse PA; Gentry GA
    Cancer Res; 1969 Jan; 29(1):79-82. PubMed ID: 5763982
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo inhibition of pyrimidine catabolism by 5-cyanouracil.
    Gentry GA; Morse PA; Dorsett MT
    Cancer Res; 1971 Jun; 31(6):909-12. PubMed ID: 5088491
    [No Abstract]   [Full Text] [Related]  

  • 10. Degradation of pyrimidines and pyrimidine analogs--pathways and mutual influences.
    Wasternack C
    Pharmacol Ther; 1980; 8(3):629-51. PubMed ID: 6992162
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.